hVIVO - New Malaria Human Challenge Model Launched

Adrian Wildfire, Director of Scientific & Business Strategy at hVIVO, a subsidiary of Open Orphan, talks to us following the announcement that hVIVO has inoculated the first cohort of volunteers with a GMP-manufactured malaria challenge agent as part of its first controlled human malaria infection challenge study.

Adrian Wildfire
Director of Scientific & Business Strategy, hVIVO

Company Events - OPEN ORPHAN